Insider Holders & Insider Ownership - Apellis Pharmaceuticals Inc. (APLS)

List of insiders holdings for Apellis Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Morningside Venture Investments Ltd
10% Owner		2022-02-14 16:05:1112,806,342
0		12,806,342Form 13G
2Potentia Holdings LLC
10% Owner		2018-02-07 18:59:553,826,601
0		3,826,601Form 13G
3Cormorant Asset Management LLC
Chen Bihua
Cormorant Global Healthcare GP LLC
Cormorant Global Healthcare Master Fund LP
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
4Cormorant Asset Management LLC
Cormorant Global Healthcare Master Fund LP
CORMORANT PRIVATE HEALTHCARE FUND I LP
Chen Bihua
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
5AJU IB Investment Co. Ltd.
10% Owner		2017-11-13 16:29:470
2,292,062		2,292,062Form 4
6Hillhouse Capital Management Ltd.
10% Owner		2019-02-14 15:15:042,098,581
0		2,098,581Form 13G
7venBio Global Strategic Fund II L.P.
10% Owner		2019-02-14 08:50:471,790,102
0		1,790,102Form 13G
8GELLERT MICHAEL E
10% Owner		2017-11-13 16:25:54943,989
0		943,989Form 4
9Machiels Alec
Director		2025-01-03 16:23:44388,227
411,950		800,177Form 4
10Axon Steven
Chief Business Officer		2018-11-15 20:40:03398,499
0		398,499Form 4
11Francois Cedric
Chief Executive Officer		2025-06-11 16:21:22287,500
0		287,500Form 4
12Dunlop A. Sinclair
Director		2025-01-03 16:17:32169,592
100,000		269,592Form 4
13Watson David O.
General Counsel		2025-06-18 08:49:34133,730
80,136		213,866Form 4
14Boucher Kelley
Chief People Officer		2025-06-11 16:27:14134,578
0		134,578Form 4
15SCHEIBLER LUKAS
Chief Research Officer		2023-12-05 19:40:46107,690
0		107,690Form 4
16Grossi Federico
Chief Medical Officer		2023-01-09 19:02:3694,884
0		94,884Form 4
17Townsend Adam J.
Chief Commercial Officer		2025-01-30 12:18:2284,050
0		84,050Form 4
18Nicholson Nur
Chief Technical Officer		2025-06-11 16:24:1082,500
0		82,500Form 4
19Sullivan Timothy Eugene
Chief Financial Officer		2025-06-11 16:20:1382,500
0		82,500Form 4
20Deschatelets Pascal
Chief Scientific Officer		2025-06-11 16:19:1382,500
0		82,500Form 4
21Baumal Caroline
Chief Medical Officer		2025-06-11 16:16:5182,500
0		82,500Form 4
22DeLong Mark Jeffrey
Chief Business & Strat Officer		2025-06-11 16:10:2382,500
0		82,500Form 4
23Lewis Karen
Chief People Officer		2025-01-30 12:12:0370,251
0		70,251Form 4
24Eisele Jeffrey
Chief Development Officer		2025-01-30 12:10:4355,312
0		55,312Form 4
25Chopas James George
VP/Chief Accounting Officer		2025-06-20 16:09:2554,205
0		54,205Form 4
26WHEELER CRAIG A
Director		2025-04-21 16:23:0144,678
0		44,678Form 4
27Celona Lucia
See Remarks		2020-02-12 16:58:2636,488
0		36,488Form 4
28FONTEYNE PAUL R.
Director		2025-01-03 16:19:3933,904
0		33,904Form 4
29O'Brien Stephanie Monaghan
Director		2025-01-03 16:25:2428,904
0		28,904Form 4
30Chan Gerald
Director		2025-01-03 16:12:4128,904
0		28,904Form 4
31Walbert Keli
Director		2025-01-10 17:39:2624,478
0		24,478Form 4
32Lackner Thomas A.
See Remarks		2020-02-12 16:50:3524,075
0		24,075Form 4
33Brown Victoria L.
Program Team Lead		2023-01-24 16:57:3223,556
0		23,556Form 4
34Sadr Ahmad
See Remarks		2020-02-12 16:46:3019,075
0		19,075Form 4
35Perry Nicole D
Vice President - Accounting		2021-08-03 16:23:5911,008
0		11,008Form 4